How do you manage patients with oligometastatic renal cell carcinoma after nephrectomy and metastatectomy?

Do you observe, offer adjuvant pembrolizumab, or give a first-line metastatic regimen (IO/IO or IO/TKI)? Does your recommendation vary based on risk classification?

Answer from: Medical Oncologist at Academic Institution

Patients with oligometastatic renal cell carcinoma after nephrectomy and metastatectomy or M1 NED represent a challenging subset of patients given the heterogeneous nature of this subset and outcomes vary with the location and timing of metastatectomy.Prior VEGF-TKI studies after metastasectomy for ...

Comments

Medical Oncologist at Mary Lanning Healthcare Morrison Cancer Center/University of Nebraska Medical Center Adjunct Faculty
Similar scenario happens with melanoma too. After ...

Please select the option that best describes you:

How do you manage patients with oligometastatic renal cell carcinoma after nephrectomy and metastatectomy?

Related Questions